SCHEMBL13734508

SCHEMBL13734508

CCOC(=O)C1CCC(N2CCN(C(C)(C)C)CC2)CC1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.47
ALDH1A1 P00352 7/20 0.44
KMT2A Q03164 6/20 0.44
MEN1 O00255 5/20 0.44
TSHR P16473 1/20 0.43
CHRM1 P11229 1/20 0.43
GAA P10253 1/20 0.41
PKM P14618 1/20 0.41
HTT P42858 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
TP53 P04637 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8260610 0.84 MAPT (0.58) MAPTALDH1A1KMT2AMEN1TSHR
SCHEMBL28443081 0.83 MAPT (0.50) MAPTALDH1A1KMT2AMEN1CHRM1
SCHEMBL28450924 0.83 MAPT (0.50) MAPTALDH1A1KMT2AMEN1CHRM1
SCHEMBL28443083 0.83 MAPT (0.50) MAPTALDH1A1KMT2AMEN1CHRM1
SCHEMBL3882849 0.83 MEN1 (0.55) MAPTALDH1A1KMT2AMEN1CHRM1
SCHEMBL2372673 0.81 MEN1 (0.57) MAPTALDH1A1KMT2AMEN1TSHR
SCHEMBL8301383 0.81 MEN1 (0.57) MAPTALDH1A1KMT2AMEN1TSHR
SCHEMBL25030105 0.81 ALDH1A1 (0.51) MAPTALDH1A1KMT2AMEN1TSHR
SCHEMBL6634545 0.81 ALDH1A1 (0.51) MAPTALDH1A1KMT2AMEN1TSHR
SCHEMBL13733825 0.81 MAPT (0.51) MAPTALDH1A1KMT2AMEN1CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012145361-A1 MODULATORS OF THE GPR119 RECEPTOR AND THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2012-10-26 WO disclosed